Trump’s new tariffs plan raises more questions
NegativeU.S News

President Trump's announcement of new pharmaceutical tariffs has sparked significant concern, particularly with the threat of a 100 percent tariff on companies that fail to establish manufacturing plants in the U.S. by October 1. This move raises questions about its potential impact on drug prices and availability, as well as the broader implications for international trade relations. As the administration pushes for domestic production, many are left wondering how this will affect consumers and the pharmaceutical industry.
— Curated by the World Pulse Now AI Editorial System